Inhaled Nitric Oxide and Neuroprotection in Premature Infants
Stopped The pace of patient enrolledment forced recruitment to stop after 273 patients.
Conditions
- Prematurity
- Bronchopulmonary Dysplasia
- Intraventricular Hemorrhage
- Periventricular Leukomalacia
Interventions
- DRUG: inhaled nitric oxide
- DRUG: oxygen
Sponsor
University of Chicago